CYP2C19*2 and CYP2C19*17 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset.

CYP2C192 and CYP2C1917 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset.

Item

http://www.wikidata.org/entity/Q38629670

Q38629670

about

Pharmacogenomics Guided-Personalization of Warfarin and Tamoxifen.Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy.

P2860

Q48125765-947FED4C-258E-4DFF-A9CD-112624B9E510 Q49554838-BEBDACC0-6088-43A3-8EDC-EB7E6E1B4170

P2860

CYP2C192 and CYP2C1917 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset.

Item

http://www.wikidata.org/entity/Q38629670

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

CYP2C19*2 and CYP2C19*17 varia ...... cogenomics Consortium dataset.

@en

type

Item

label

CYP2C19*2 and CYP2C19*17 varia ...... cogenomics Consortium dataset.

@en

prefLabel

CYP2C19*2 and CYP2C19*17 varia ...... cogenomics Consortium dataset.

@en

P1476

CYP2C19*2 and CYP2C19*17 varia ...... acogenomics Consortium dataset

@en

P2093

Anatasha Crawford

http://www.w3.org/2001/XMLSchema#string

Carl Langefeld

http://www.w3.org/2001/XMLSchema#string

Deidre Cronin-Fenton

http://www.w3.org/2001/XMLSchema#string

Emilius A M Janssen

http://www.w3.org/2001/XMLSchema#string

Kimberly A Barker

http://www.w3.org/2001/XMLSchema#string

Timothy L Lash

http://www.w3.org/2001/XMLSchema#string

Ylva Hellberg

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacogenomics knowledge for personalized medicine

Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese

The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans

The pharmacology and clinical uses of tamoxifen

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.

Identification of human CYP forms involved in the activation of tamoxifen and irreversible binding to DNA.

Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer

Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17

P2888

s41598-017-08091-x

P304

7727

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-08091-X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Thomas P Ahern

Per Damkier

Anders Kjærsgaard

P577

2017-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091144604

http://www.w3.org/2001/XMLSchema#string

P698

28798474

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics

P932

5552748

http://www.w3.org/2001/XMLSchema#string

CYP2C19*2 and CYP2C19*17 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset.

about

P2860

P2860

CYP2C19*2 and CYP2C19*17 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932

CYP2C192 and CYP2C1917 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset.

CYP2C192 and CYP2C1917 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset.